AAPL354.17+22.27 (+6.71%) ▲|ABBV290.98+4.98 (+1.74%) ▲|ABT115.80+6.40 (+5.85%) ▲|ACN265.42+10.86 (+4.27%) ▲|ADBE248.70+2.56 (+1.04%) ▲|AMAT367.23-14.69 (-3.85%) ▼|AMD483.11-0.79 (-0.16%) ▼|AMGN479.06+17.80 (+3.86%) ▲|AMT192.97+5.68 (+3.03%) ▲|AMZN269.85+19.16 (+7.64%) ▲|AVGO328.55-3.58 (-1.08%) ▼|AXP331.91+6.41 (+1.97%) ▲|BA176.43+3.12 (+1.80%) ▲|BAC51.26+1.60 (+3.22%) ▲|BKNG172.66+16.99 (+10.91%) ▲|BLK1,226.83+65.51 (+5.64%) ▲|BMY63.17+1.46 (+2.37%) ▲|BNY151.80+2.49 (+1.67%) ▲|BRK-B573.67+16.60 (+2.98%) ▲|C124.67+1.96 (+1.59%) ▲|CAT583.28-40.66 (-6.52%) ▼|CL98.62+3.00 (+3.13%) ▲|CMCSA24.70+1.03 (+4.33%) ▲|COF206.73-1.98 (-0.95%) ▼|COP135.77-8.63 (-5.98%) ▼|COST1,047.09+27.83 (+2.73%) ▲|CRM226.38+4.18 (+1.88%) ▲|CSCO102.47-0.50 (-0.49%) ▼|CVS79.72-11.69 (-12.79%) ▼|CVX215.19-10.08 (-4.47%) ▼|DE674.85+9.02 (+1.35%) ▲|DHR234.53+4.42 (+1.92%) ▲|DIS119.67+5.49 (+4.81%) ▲|DUK129.58+3.07 (+2.43%) ▲|EMR171.29+4.90 (+2.94%) ▲|FDX324.63+6.61 (+2.08%) ▲|GD366.11-8.39 (-2.24%) ▼|GE331.92+11.25 (+3.51%) ▲|GEV817.75-100.46 (-10.94%) ▼|GILD174.38+6.91 (+4.13%) ▲|GM92.71+4.37 (+4.95%) ▲|GOOG290.38+12.11 (+4.35%) ▲|GOOGL291.98+11.95 (+4.27%) ▲|GS928.17+32.08 (+3.58%) ▲|HD351.94+18.28 (+5.48%) ▲|HON230.27+6.22 (+2.78%) ▲|IBM255.01+4.97 (+1.99%) ▲|INTC58.37-2.18 (-3.60%) ▼|INTU356.67+11.95 (+3.47%) ▲|ISRG484.97+44.22 (+10.03%) ▲|JNJ273.55+7.38 (+2.77%) ▲|JPM351.27+13.29 (+3.93%) ▲|KO95.91+1.11 (+1.17%) ▲|LIN525.83+14.28 (+2.79%) ▲|LLY1,421.57+12.19 (+0.86%) ▲|LMT595.60-43.40 (-6.79%) ▼|LOW228.04+14.66 (+6.87%) ▲|LRCX222.70-8.02 (-3.48%) ▼|MA668.15+20.97 (+3.24%) ▲|MCD278.17+15.13 (+5.75%) ▲|MDLZ67.74+2.62 (+4.02%) ▲|MDT105.06+6.18 (+6.24%) ▲|META635.97+14.94 (+2.41%) ▲|MMM194.30+17.25 (+9.74%) ▲|MO78.04+1.10 (+1.43%) ▲|MRK148.87+4.20 (+2.90%) ▲|MS192.83+6.74 (+3.62%) ▲|MSFT555.51+34.52 (+6.62%) ▲|MU807.80-47.30 (-5.53%) ▼|NEE88.53+4.20 (+4.98%) ▲|NFLX65.97+2.55 (+4.01%) ▲|NKE40.54+2.06 (+5.35%) ▲|NOW109.05-0.11 (-0.10%) ▼|NVDA203.89-2.80 (-1.35%) ▼|ORCL125.47-0.72 (-0.57%) ▼|PEP142.87+5.60 (+4.08%) ▲|PFE30.71+0.71 (+2.35%) ▲|PG167.12+5.06 (+3.12%) ▲|PLTR171.27-4.13 (-2.35%) ▼|PM210.67+2.64 (+1.27%) ▲|QCOM168.40+3.97 (+2.41%) ▲|RTX197.50-6.32 (-3.10%) ▼|SBUX108.51+3.74 (+3.57%) ▲|SCHW93.00+3.72 (+4.17%) ▲|SO93.23-0.52 (-0.55%) ▼|SPG227.90+5.82 (+2.62%) ▲|T21.79+0.40 (+1.85%) ▲|TMO706.09+7.75 (+1.11%) ▲|TMUS159.83+5.42 (+3.51%) ▲|TSLA389.00-9.50 (-2.38%) ▼|TXN311.09-1.41 (-0.45%) ▼|UBER71.47+4.87 (+7.31%) ▲|UNH408.87+4.43 (+1.09%) ▲|UNP307.94+4.51 (+1.48%) ▲|UPS114.06+4.89 (+4.47%) ▲|USB60.78+0.89 (+1.49%) ▲|V432.14+11.72 (+2.79%) ▲|VZ46.09+0.85 (+1.88%) ▲|WFC86.82+1.29 (+1.50%) ▲|WMT130.25+5.39 (+4.32%) ▲|XOM169.04-8.42 (-4.74%) ▼|AAPL354.17+22.27 (+6.71%) ▲|ABBV290.98+4.98 (+1.74%) ▲|ABT115.80+6.40 (+5.85%) ▲|ACN265.42+10.86 (+4.27%) ▲|ADBE248.70+2.56 (+1.04%) ▲|AMAT367.23-14.69 (-3.85%) ▼|AMD483.11-0.79 (-0.16%) ▼|AMGN479.06+17.80 (+3.86%) ▲|AMT192.97+5.68 (+3.03%) ▲|AMZN269.85+19.16 (+7.64%) ▲|AVGO328.55-3.58 (-1.08%) ▼|AXP331.91+6.41 (+1.97%) ▲|BA176.43+3.12 (+1.80%) ▲|BAC51.26+1.60 (+3.22%) ▲|BKNG172.66+16.99 (+10.91%) ▲|BLK1,226.83+65.51 (+5.64%) ▲|BMY63.17+1.46 (+2.37%) ▲|BNY151.80+2.49 (+1.67%) ▲|BRK-B573.67+16.60 (+2.98%) ▲|C124.67+1.96 (+1.59%) ▲|CAT583.28-40.66 (-6.52%) ▼|CL98.62+3.00 (+3.13%) ▲|CMCSA24.70+1.03 (+4.33%) ▲|COF206.73-1.98 (-0.95%) ▼|COP135.77-8.63 (-5.98%) ▼|COST1,047.09+27.83 (+2.73%) ▲|CRM226.38+4.18 (+1.88%) ▲|CSCO102.47-0.50 (-0.49%) ▼|CVS79.72-11.69 (-12.79%) ▼|CVX215.19-10.08 (-4.47%) ▼|DE674.85+9.02 (+1.35%) ▲|DHR234.53+4.42 (+1.92%) ▲|DIS119.67+5.49 (+4.81%) ▲|DUK129.58+3.07 (+2.43%) ▲|EMR171.29+4.90 (+2.94%) ▲|FDX324.63+6.61 (+2.08%) ▲|GD366.11-8.39 (-2.24%) ▼|GE331.92+11.25 (+3.51%) ▲|GEV817.75-100.46 (-10.94%) ▼|GILD174.38+6.91 (+4.13%) ▲|GM92.71+4.37 (+4.95%) ▲|GOOG290.38+12.11 (+4.35%) ▲|GOOGL291.98+11.95 (+4.27%) ▲|GS928.17+32.08 (+3.58%) ▲|HD351.94+18.28 (+5.48%) ▲|HON230.27+6.22 (+2.78%) ▲|IBM255.01+4.97 (+1.99%) ▲|INTC58.37-2.18 (-3.60%) ▼|INTU356.67+11.95 (+3.47%) ▲|ISRG484.97+44.22 (+10.03%) ▲|JNJ273.55+7.38 (+2.77%) ▲|JPM351.27+13.29 (+3.93%) ▲|KO95.91+1.11 (+1.17%) ▲|LIN525.83+14.28 (+2.79%) ▲|LLY1,421.57+12.19 (+0.86%) ▲|LMT595.60-43.40 (-6.79%) ▼|LOW228.04+14.66 (+6.87%) ▲|LRCX222.70-8.02 (-3.48%) ▼|MA668.15+20.97 (+3.24%) ▲|MCD278.17+15.13 (+5.75%) ▲|MDLZ67.74+2.62 (+4.02%) ▲|MDT105.06+6.18 (+6.24%) ▲|META635.97+14.94 (+2.41%) ▲|MMM194.30+17.25 (+9.74%) ▲|MO78.04+1.10 (+1.43%) ▲|MRK148.87+4.20 (+2.90%) ▲|MS192.83+6.74 (+3.62%) ▲|MSFT555.51+34.52 (+6.62%) ▲|MU807.80-47.30 (-5.53%) ▼|NEE88.53+4.20 (+4.98%) ▲|NFLX65.97+2.55 (+4.01%) ▲|NKE40.54+2.06 (+5.35%) ▲|NOW109.05-0.11 (-0.10%) ▼|NVDA203.89-2.80 (-1.35%) ▼|ORCL125.47-0.72 (-0.57%) ▼|PEP142.87+5.60 (+4.08%) ▲|PFE30.71+0.71 (+2.35%) ▲|PG167.12+5.06 (+3.12%) ▲|PLTR171.27-4.13 (-2.35%) ▼|PM210.67+2.64 (+1.27%) ▲|QCOM168.40+3.97 (+2.41%) ▲|RTX197.50-6.32 (-3.10%) ▼|SBUX108.51+3.74 (+3.57%) ▲|SCHW93.00+3.72 (+4.17%) ▲|SO93.23-0.52 (-0.55%) ▼|SPG227.90+5.82 (+2.62%) ▲|T21.79+0.40 (+1.85%) ▲|TMO706.09+7.75 (+1.11%) ▲|TMUS159.83+5.42 (+3.51%) ▲|TSLA389.00-9.50 (-2.38%) ▼|TXN311.09-1.41 (-0.45%) ▼|UBER71.47+4.87 (+7.31%) ▲|UNH408.87+4.43 (+1.09%) ▲|UNP307.94+4.51 (+1.48%) ▲|UPS114.06+4.89 (+4.47%) ▲|USB60.78+0.89 (+1.49%) ▲|V432.14+11.72 (+2.79%) ▲|VZ46.09+0.85 (+1.88%) ▲|WFC86.82+1.29 (+1.50%) ▲|WMT130.25+5.39 (+4.32%) ▲|XOM169.04-8.42 (-4.74%) ▼|
22.1 C
New York
Wednesday, November 4, 2026

Tag: products

LYNO AI Presale Gains Momentum as Over 100,000 Tokens Sold in Early Bird Stage

ROAD TOWN, British Virgin Islands, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LYNO AI, a cross-chain arbitrage protocol powered by artificial intelligence, has officially entered its presale phase, with over 100,391 LYNO tokens already sold. The protocol, which enables automated real-time arbitrage trading across 15+ EVM-compatible networks, is now attracting significant early participation from investors seeking exposure to cutting-edge DeFi infrastructure.

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

BEIJING, Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient...

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

BEIJING, Aug. 4, 2025 /PRNewswire/ -- Raytone Biotech, a biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing...

SOHU.COM REPORTS SECOND QUARTER 2025 UNAUDITED FINANCIAL RESULTS

BEIJING, Aug. 4, 2025 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or the "Company"), a leading Chinese online media platform and game business group, today...

Advancing Global Tourism Industry Trade: Tourism Plus Shanghai 2026 Calls for Worldwide Exhibitors

SHANGHAI, Aug. 4, 2025 /PRNewswire/ -- From March 29th to April 3rd, 2026, Tourism Plus Shanghai (TPS 2026) will convene over 6,000 global exhibitors in...

RHB, TOKIO MARINE LIFE AND TAKAFUL MALAYSIA FORGE LONG TERM EXCLUSIVE BANCA PARTNERSHIPS

KUALA LUMPUR, Malaysia, Aug. 4, 2025 /PRNewswire/ -- RHB Banking Group ("RHB" or the "Group") entered into bancassurance and bancatakaful partnerships with Tokio Marine Life...

Advancing Global Tourism Industry Trade: Tourism Plus Shanghai 2026 Calls for Worldwide Exhibitors

SHANGHAI, Aug. 3, 2025 /PRNewswire/ -- From March 29th to April 3rd, 2026, Tourism Plus Shanghai (TPS 2026) will convene over 6,000 global exhibitors in...

Alphamab Oncology Announces IND Application for Innovative PD-L1/αvβ6 Bispecific ADC JSKN022 was Officially Accepted by CDE

SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN022, an independently...

Zepp Health Corporation Reports Second Quarter 2025 Unaudited Financial Results

MILPITAS, Calif., Aug. 3, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the...

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities...

SAN DIEGO, Aug. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), have until Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers and certain of Hims & Hers’ executives with violations of the Securities Exchange Act of 1934. A subsequently filed complaint is captioned Yaghsizian v. Hims & Hers Health, Inc., No. 25-cv-05321 (N.D. Cal.).

Eliquid Base Launches Compliant Prefilled Pod Kit as Legal Alternative to Banned Disposable Vapes in the UK

MANCHESTER, United Kingdom, Aug. 03, 2025 (GLOBE NEWSWIRE) -- With the UK government's 2025 disposable vape ban now in effect to tackle environmental concerns and reduce health risks, millions of vapers are left seeking legal and reliable alternatives. Eliquid Base, one of the UK's leading online vape retailers, has stepped up with a robust solution; the launch of compliant prefilled pod kits that align with UK TPD regulations, offering the same convenience and flavour experience as disposables without breaching the new rules.

United Imaging Teases Multi-modality “Provider Success” Product Launches at AHRA 2025

The newly FDA-cleared uMR® Ultra and the uOmniscan™ are the first major announcements leading into the AHRA Annual Meeting in Las Vegas. HOUSTON, Aug. 3, 2025...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProducts